Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
EXPENSES
Research and development	$ 6,707	$ 5,113	$ 13,804	$ 7,912
General and administrative	5,856	3,318	11,653	6,501
Total operating expenses	12,563	8,431	25,457	14,413
OTHER INCOME (EXPENSE)
Interest income	192	833	514	1,201
Interest expense [note 6]	(191)	(804)	(376)	(1,617)
Change in fair value of contingent consideration [note 4 and note 5]	(97)	(57)	(188)	(109)
Other expense	(59)	(2)	(38)	(17)
Total other income (expense)	(155)	(30)	(88)	(542)
Net loss	(12,718)	(8,461)	(25,545)	(14,955)
OTHER COMPREHENSIVE LOSS
Net unrealized loss on marketable securities	(3)	(11)	(28)	(11)
Total other comprehensive loss	(3)	(11)	(28)	(11)
Comprehensive loss	$ (12,721)	$ (8,472)	$ (25,573)	$ (14,966)
Basic net loss per common share [note 7[d]]	$ (0.37)	$ (0.25)	$ (0.74)	$ (0.5)
Diluted net loss per common share [note 7[d]]	$ (0.37)	$ (0.25)	$ (0.74)	$ (0.5)
Weighted average shares used in computation of basic net loss per common share [note 7[d]]	34,685,072	34,318,709	34,685,072	29,683,422
Weighted average shares used in computation of diluted net loss per common share [note 7[d]]	34,685,072	34,318,709	34,685,072	29,683,422